Pfizer Vaccine Effective in Children Under 5, the F.D.A. Saysnews2022-06-13T02:52:13+00:00June 13th, 2022|The New York Times|
Vaccines for young children are being delayed by incomplete data, a top F.D.A. official suggests.news2022-04-26T23:00:56+00:00April 26th, 2022|The New York Times|
Covid Drugs Save Lives, but Americans Can’t Get Themnews2022-04-22T20:51:23+00:00April 22nd, 2022|The New York Times|
Pfizer Says Booster Strengthens Immune Response for Children 5 to 11news2022-04-14T22:14:31+00:00April 14th, 2022|The New York Times|
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Oldernews2022-03-29T23:44:53+00:00March 29th, 2022|The New York Times|
Biden Administration Plans to Offer Second Booster Shots to Those 50 and Upnews2022-03-26T14:29:54+00:00March 26th, 2022|The New York Times|
Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Childrennews2022-03-23T22:18:57+00:00March 23rd, 2022|The New York Times|
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risknews2022-03-23T20:29:21+00:00March 23rd, 2022|The New York Times|
¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
